Literature DB >> 17223480

Disseminated tuberculosis after anti-TNFalpha treatment.

Aruna S Malipeddi1, Rajesh Rajendran, George Kallarackal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223480     DOI: 10.1016/S0140-6736(07)60078-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Mycobacterium tuberculosis: sometimes, a hidden culprit.

Authors:  Miguel F Carrascosa; José-Ramón Salcines Caviedes; Marta C Hoz; Carmen R Talledo
Journal:  BMJ Case Rep       Date:  2011-07-27

2.  Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluation.

Authors:  François Maignen; Manfred Hauben; Panos Tsintis
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

3.  Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.

Authors:  Steffen Hess; Toni Hospach; Robert Nossal; Günther Dannecker; Klaus Magdorf; Frank Uhlemann
Journal:  Eur J Pediatr       Date:  2011-05-31       Impact factor: 3.183

4.  [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].

Authors:  R Diel; B Hauer; R Loddenkemper; B Manger; K Krüger
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

Review 5.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation.

Authors:  Shahrad Hakimian; Yevgeniy Popov; Abbas H Rupawala; Karen Salomon-Escoto; Steven Hatch; Randall Pellish
Journal:  Biologics       Date:  2018-02-27

7.  HOW TO TREAT PATIENTS AFTER SERIOUS ADVERSE EFFECTS CAUSED BY TNF INHIBITORS?

Authors:  Saša Sršen; Eugenija Marušić; Vitomir Metličić; Luka Stričević; Marijan Frković; Marija Jelušić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.